NEFL and Spinocerebellar ataxia type 3: Therefore, we used the YACQ84 mouse, known to exhibit clinically relevant aspects of SCA3 pathogenesis (Cemal et al., 2002; Costa et al., 2013; McLoughlin et al., 2018; Moore et al., 2017), to investigate blood NfL changes throughout disease progression.